Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gross

Showing results (191-200 of 244) with videos related to

Pageof 25
Sort By:
BMJ Global Health|January 16, 2026
Finding the balance between academic productivity and impact: evaluation of the Botswana - University of Pennsylvania partnership over a 5-year timeframeCorrado Cancedda, Merrian Brooks, Oathokwa Nkomazana, et al.
The Journal of Infectious Diseases|September 10, 2003
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppressionEmmanouil Papasavvas, Johan K Sandberg, Richard Rutstein, et al.
The Pharmacogenomics Journal|June 2, 2018
Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in BotswanaMarijana Vujkovic, Scarlett L Bellamy, Athena F Zuppa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 9, 2017
Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in BotswanaMarijana Vujkovic, Scarlett L Bellamy, Athena F Zuppa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 2010
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patientsTimothy J Wilkin, Zhaohui Su, Amy Krambrink, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2012
A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illnessMichael B Blank, Nancy P Hanrahan, Martin Fishbein, et al.
Drug and Alcohol Dependence|January 18, 2016
Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individualsRaquel B De Boni, Lu Zheng, Susan L Rosenkranz, et al.
Journal of Clinical Immunology|January 19, 2006
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruptionEmmanouil Papasavvas, Jay R Kostman, Brian Thiel, et al.
The Lancet. Digital Health|September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trialRobert Gross, Justin Ritz, Michael D Hughes, et al.
AIDS and Behavior|November 12, 2013
The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as preventionRobert H Remien, Curtis Dolezal, Glenn J Wagner, et al.
Pageof 25

Showing results (191-200 of 244) with videos related to

Sort By:
Pageof 25
BMJ Global Health|January 16, 2026
Finding the balance between academic productivity and impact: evaluation of the Botswana - University of Pennsylvania partnership over a 5-year timeframeCorrado Cancedda, Merrian Brooks, Oathokwa Nkomazana, et al.
The Journal of Infectious Diseases|September 10, 2003
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppressionEmmanouil Papasavvas, Johan K Sandberg, Richard Rutstein, et al.
The Pharmacogenomics Journal|June 2, 2018
Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in BotswanaMarijana Vujkovic, Scarlett L Bellamy, Athena F Zuppa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 9, 2017
Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in BotswanaMarijana Vujkovic, Scarlett L Bellamy, Athena F Zuppa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 2010
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patientsTimothy J Wilkin, Zhaohui Su, Amy Krambrink, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2012
A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illnessMichael B Blank, Nancy P Hanrahan, Martin Fishbein, et al.
Drug and Alcohol Dependence|January 18, 2016
Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individualsRaquel B De Boni, Lu Zheng, Susan L Rosenkranz, et al.
Journal of Clinical Immunology|January 19, 2006
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruptionEmmanouil Papasavvas, Jay R Kostman, Brian Thiel, et al.
The Lancet. Digital Health|September 19, 2019
Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trialRobert Gross, Justin Ritz, Michael D Hughes, et al.
AIDS and Behavior|November 12, 2013
The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as preventionRobert H Remien, Curtis Dolezal, Glenn J Wagner, et al.
Pageof 25